Skip to main content
A

Abnova (Taiwan) Corporation — Investor Relations & Filings

Ticker · 4133 TW Professional, scientific and technical activities
Filings indexed 1,474 across all filing types
Latest filing 2020-10-06 Regulatory Filings
Country TW Taiwan
Listing TW 4133

About Abnova (Taiwan) Corporation

http://www.abnova.com

Abnova Corporation is a global leader in the high-throughput production of antibodies and recombinant proteins. By integrating industrial-scale manufacturing with IT-driven management systems, the company maintains one of the world's largest catalogs of biological reagents. Its core offerings encompass gene synthesis, cytogenetics, peptide services, and protein expression. Abnova provides comprehensive solutions for life science research, including custom antibody production, scale-up, and humanization. Recent technological expansions include the RNAutomation™ mRNA service, NanoAb™ services, and nanoCAR-T mRNA solutions. The company supports academic and industrial researchers across multidisciplinary fields with integrated assay development and advanced bioreagent tools.

Recent filings

Filing Released Lang Actions
係因本公司有價證券於集中交易市場達公布注意交易資訊標準, 故公布相關財務業務等重大訊息,以利投資人區別瞭解。
Regulatory Filings
2020-10-06 Chinese
本公司受邀參加凱基證劵舉辦之線上法人說明會
Regulatory Filings
2020-09-22 Chinese
109年09月法人說明會簡報 — 413320200922E002.pdf
Regulatory Filings
2020-09-22 Chinese
109年09月法人說明會簡報 — 413320200922M002.pdf
Regulatory Filings
2020-09-22 Chinese
109年09月法人說明會簡報
Regulatory Filings
2020-09-22 Chinese
109年08月內部人持股異動(事後)
Regulatory Filings
2020-09-07 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.